Iridian Asset Management LLC Charles River Laboratories International, Inc. Transaction History

Iridian Asset Management LLC

$359 Million
Q4 2024

A detailed history of Iridian Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 50,965 shares of CRL stock, worth $7.89 Million. This represents 2.62% of its overall portfolio holdings.

Number of Shares

50,965

Previous 55,043 7.41%

Holding current value

$7.89 Million

Previous $10.8 Million 13.23%

% of portfolio

2.62%

Previous 2.43%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$178.58 - $220.69 $728,249 - $899,973	-4,078 Reduced 7.41%	50,965 $9.41 Million
Q3 2024 Oct 25, 2024	BUY	$187.96 - $245.29 $1.67 Million - $2.18 Million	8,876 Added 19.23%	55,043 $10.8 Million
Q2 2024 Jul 26, 2024	BUY	$206.39 - $268.73 $4.49 Million - $5.85 Million	21,763 Added 89.18%	46,167 $9.54 Million
Q1 2024 May 01, 2024	SELL	$203.52 - $273.43 $1.37 Million - $1.84 Million	-6,738 Reduced 21.64%	24,404 $6.61 Million
Q4 2023 Jan 26, 2024	BUY	$164.52 - $238.84 $296,629 - $430,628	1,803 Added 6.15%	31,142 $7.36 Million
Q3 2023 Oct 30, 2023	SELL	$194.44 - $217.61 $7.4 Million - $8.28 Million	-38,039 Reduced 56.46%	29,339 $5.75 Million
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $240,476 - $275,217	1,309 Added 1.98%	67,378 $14.2 Million
Q1 2023 Apr 28, 2023	SELL	$191.89 - $259.92 $2.42 Million - $3.28 Million	-12,607 Reduced 16.02%	66,069 $13.3 Million
Q4 2022 Jan 31, 2023	SELL	$197.11 - $250.07 $1.83 Million - $2.32 Million	-9,288 Reduced 10.56%	78,676 $17.1 Million
Q3 2022 Nov 07, 2022	SELL	$182.44 - $250.54 $870,421 - $1.2 Million	-4,771 Reduced 5.14%	87,964 $17.3 Million
Q2 2022 Jul 29, 2022	BUY	$204.13 - $302.4 $3.72 Million - $5.52 Million	18,245 Added 24.49%	92,735 $19.8 Million
Q1 2022 May 02, 2022	BUY	$255.51 - $362.11 $4.08 Million - $5.78 Million	15,974 Added 27.3%	74,490 $21.2 Million
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $18.4 Million - $23.5 Million	-52,277 Reduced 47.18%	58,516 $22 Million
Q3 2021 Nov 10, 2021	SELL	$372.64 - $458.3 $35.5 Million - $43.7 Million	-95,394 Reduced 46.27%	110,793 $45.7 Million
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $10.2 Million - $12.9 Million	-34,754 Reduced 14.42%	206,187 $76.3 Million
Q1 2021 May 11, 2021	SELL	$249.67 - $299.48 $9.88 Million - $11.8 Million	-39,566 Reduced 14.11%	240,941 $69.8 Million
Q4 2020 Feb 08, 2021	SELL	$222.0 - $252.62 $9.47 Million - $10.8 Million	-42,648 Reduced 13.2%	280,507 $70.1 Million
Q3 2020 Nov 02, 2020	SELL	$175.56 - $226.45 $19.9 Million - $25.7 Million	-113,625 Reduced 26.01%	323,155 $73.2 Million
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $4.8 Million - $7.66 Million	-40,377 Reduced 8.46%	436,780 $76.2 Million
Q1 2020 May 11, 2020	BUY	$98.9 - $178.34 $26.3 Million - $47.5 Million	266,270 Added 126.26%	477,157 $60.2 Million
Q4 2019 Feb 03, 2020	BUY	$126.05 - $152.76 $26.6 Million - $32.2 Million	210,887 New	210,887 $32.2 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

51.4M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.88B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.

Account

Iridian Asset Management LLC Charles River Laboratories International, Inc. Transaction History